Heparin-induced thrombocytopenia

Disease-a-Month

Volumn 51, Issue 2-3, 2005, Pages 141-149

  Warkentin, Theodore E ^a,b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON REGIONAL LABORATORY MEDICINE PROGRAM   (Canada)

^c HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ARGATROBAN; COUMARIN; DANAPAROID; FONDAPARINUX; HEPARIN; HIRULOG; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN INHIBITOR; VITAMIN K GROUP; WARFARIN;

ANAPHYLAXIS; BLOOD CLOTTING; CARDIOVASCULAR RISK; CELL ASSAY; CHILL; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DIARRHEA; DRUG EFFICACY; DRUG FEVER; DYSPNEA; ERYTHEMA; FLUSHING; GANGRENE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HYPERTENSION; IMMUNOASSAY; LABORATORY TEST; LIMB ISCHEMIA; PATHOGENESIS; PHLEGMASIA CERULEA DOLENS; POSTOPERATIVE COMPLICATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SIDE EFFECT; SKIN DISEASE; SKIN NECROSIS; TACHYCARDIA; TACHYPNEA; THORAX PAIN; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOPLASTIN TIME; TISSUE NECROSIS; TRANSIENT GLOBAL AMNESIA; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

EID: 19344362639     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2005.03.009     Document Type: Article

References (28)

1. T.E. Warkentin Heparin-induced thrombocytopenia pathogenesis and management Br J Haematol 121 2003 535 555
2. Y. Gruel, C. Pouplard, P. Nguyen Biological and clinical features of low-molecular-weight heparin-induced thrombocytopenia Br J Haematol 121 2003 786 792
3. T.E. Warkentin, M.N. Levine, J. Hirsh Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin N Engl J Med 332 1995 1330 1335
4. T.E. Warkentin, R.S. Roberts, J. Hirsh An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients Arch Intern Med 163 2003 2518 2524
5. D.H. Lee, T.E. Warkentin Frequency of heparin-induced thrombocytopenia T.E. Warkentin A. Greinacher Heparin-Induced Thrombocytopenia 3rd ed. 2004 Marcel Dekker, Inc New York 107 148
6. T.E. Warkentin, C.S. Sigouin Gender and risk of immune heparin-induced thrombocytopenia Blood 100 suppl 1 2002 17a [abstract]
7. Z.Q. Li, W. Liu, K.S. Park Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody Blood 99 2002 1230 1236
8. T.E. Warkentin, J.G. Kelton A 14-year study of heparin-induced thrombocytopenia Am J Med 101 1996 502 507
9. D.E. Wallis, D.L. Workman, B.E. Lewis Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia Am J Med 106 1999 629 635
10. T.E. Warkentin Clinical picture of heparin-induced thrombocytopenia T.E. Warkentin A. Greinacher Heparin-Induced Thrombocytopenia 3rd ed. 2004 Marcel Dekker, Inc New York 53 106
11. T.E. Warkentin, N.M. Heddle Laboratory diagnosis of immune heparin-induced thrombocytopenia Curr Hematol Rep 2 2003 148 157
12. G.K. Lo, T.E. Warkentin Preliminary evaluation of a clinical scoring system for estimating the pretest probability of heparin-induced thrombocytopenia the "4 T's" Blood 102 suppl 1 2003 535a [abstract]
13. T.E. Warkentin, J.G. Kelton Temporal aspects of heparin-induced thrombocytopenia N Engl J Med 344 2001 1286 1292
14. T.E. Warkentin, A. Greinacher Heparin-induced thrombocytopenia: recognition, treatment, and prevention. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 suppl 2004 311S 337S
15. T.E. Warkentin Management of heparin-induced thrombocytopenia a critical comparison of lepirudin and argatroban Thromb Res 110 2003 73 82
16. T.E. Warkentin, J.G. Kelton Delayed-onset heparin-induced thrombocytopenia and thrombosis Ann Intern Med 135 2001 502 506
17. T.E. Warkentin, L.J. Elavathil, C.P.M. Hayward The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia Ann Intern Med 127 1997 804 812
18. G.P. Visentin, M. Moghaddam, S.E. Beery Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/ thrombosis J Lab Clin Med 138 2001 22 31
19. T.E. Warkentin, C.P.M. Hayward, C.A. Smith Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia J Lab Clin Med 120 1992 371 379
20. T.E. Warkentin, J.I. Sheppard, J.C. Moore Laboratory testing for HIT antibodies how much class do we need? Blood 104 2004 825a [abstract]
21. Warkentin TE. Coumarin-induced skin necrosis and venous limb gangrene. In: Colman RW, Marder VJ, Clowes AW, et al, editors. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 5th ed. New York: Lippincott Williams & Wilkins, (in press).
22. T.E. Warkentin Bivalent direct thrombin inhibitors hirudin and bivalirudin Best Pract Res Clin Haematol 17 2004 105 125
23. A. Greinacher Lepirudin a bivalent direct thrombin inhibitor for anticoagulation therapy Exp Rev Cardiovasc Ther 2 2004 339 357
24. N. Lubenow, P. Eichler, T. Lietz Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia an analysis of 3 prospective studies Blood 104 2004 3072 3077
25. A. Greinacher, P. Eichler, N. Lubenow Heparin-induced thrombocytopenia with thromboembolic complications meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range Blood 96 2000 846 851
26. A. Greinacher, N. Lubenow, P. Eichler Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia Circulation 108 2003 2062 2065
27. B.E. Lewis, D.E. Wallis, S.D. Berkowitz Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia Circulation 103 2001 1838 1843
28. B.E. Lewis, D.E. Wallis, F. Leya Argatroban anticoagulation in patients with heparin-induced thrombocytopenia Arch Intern Med 163 2003 1849 1856